companydata.dkcompanydata.dk

XO CARE A/S: Financial statements 2022

CVR: 46936728

Source: annual report 2022, Danish Business Authority

01/10/2021 – 30/09/2022

XO CARE A/S (CVR 46936728) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 58,197,859 and a net result of DKK 5,243,773 compared with DKK 4,521,169 the year before. That is an increase of 13.8% compared with the year before. Equity in the 2022 report amounted to DKK 22,588,092. The solvency ratio was 32%. The company had 69 employees in the financial year.

Gross Profit
DKK 58,197,859
Profit/Loss
DKK 5,243,773
Equity
DKK 22,588,092
Total Assets
DKK 70,487,717
Employees
69

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-58.2M5.2M22.6M69
2021-51.2M4.5M22.8M58
2020-24.4M223K21.3M50
2019-31.8M2.9M25.1M62
2018-38.4M6.6M26.2M61

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on XO CARE A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Ulrik Berthelsen joins XO CARE A/S as adm. dir.Aug 15, 2022

As of August 15, 2022, Ulrik Berthelsen is registered as adm. dir. of XO CARE A/S.

Leif Kim Sørensen steps down as adm. dir. of XO CARE A/SAug 15, 2022

As of August 15, 2022, Leif Kim Sørensen has stepped down as adm. dir. of XO CARE A/S.

Frank Egon Offenberg joins the board of XO CARE A/SMar 18, 2022

As of March 18, 2022, Frank Egon Offenberg has joined the board of directors of XO CARE A/S.

Preben Falch Hansen leaves the board of XO CARE A/SMar 18, 2022

As of March 18, 2022, Preben Falch Hansen has left the board of directors of XO CARE A/S.

About XO CARE A/S

XO CARE A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 1973. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The company was previously named FLEX DENTAL A/S and DEN-FLEX A/S. The management consists of Mark Christian Hvidberg da Silva. The board consists of Per Ola Fredrik Ideström (chair), Gustav Jungdalen Lundgren, Frank Egon Offenberg and Henrik Nielsen. The company is owned by Impilo MedTech Invest AB. The company has 68 employees (2026). In 2025, the company reported a gross profit of DKK 52,843,204 and a net result of DKK 7,160,810 compared with DKK 3,330,008 the year before. Equity in the 2025 report amounted to DKK 32,916,525.

Source: annual report 2025, Danish Business Authority